Ligand Pharmaceuticals Incorporated
DE ˙ DB ˙ US53220K5048
198,00 € ↑2,00 (1,02%)
2026-06-04
PREZZO DELLE AZIONI
SecurityDE:LGDN / Ligand Pharmaceuticals Incorporated
InstitutionAlliancebernstein L.p.
Latest Disclosed Ownership24,295 shares
Latest Disclosed Value $ 4,593,456
Alliancebernstein L.p. reports 0.51% increase in ownership of LGDN / Ligand Pharmaceuticals Incorporated

On May 15, 2026 - Alliancebernstein L.p. filed a 13F-HR form disclosing ownership of 24,295 shares of Ligand Pharmaceuticals Incorporated (DE:LGDN) valued at $4,130,150 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 24,171 shares of Ligand Pharmaceuticals Incorporated. This represents a change in shares of 0.51% during the quarter. The current value of the position is $4,810,410 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 24,295 124 0.51 4,593 0.50 0.0015
2026-02-17 2025-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 24,171 1,918 8.62 4,570 15.96 0.0014
2025-11-14 2025-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 22,253 1,576 7.62 3,942 67.70 0.0012
2025-08-14 2025-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 20,677 0 0.00 2,351 8.15 0.0008
2025-05-15 2025-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 20,677 31 0.15 2,174 -1.76 0.0008
2025-02-12 2024-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 20,646 -1,460 -6.60 2,212 0.00 0.0008
2024-11-14 2024-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 22,106 0 0.00 2,213 18.80 0.0007
2024-08-14 2024-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 22,106 -913 -3.97 1,863 10.70 0.0006
2024-05-14 2024-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 23,019 1,460 6.77 1,683 9.29 0.0006
2024-02-14 2023-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 21,559 -20 -0.09 1,540 19.03 0.0006
2023-11-14 2023-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 21,579 0 0.00 1,293 -16.85 0.0006
2023-08-15 2023-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 21,579 -2,311 -9.67 1,556 -11.50 0.0006
2023-05-15 2023-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 23,890 -1,434 -5.66 1,757 3.90 0.0008
2023-02-15 2022-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 25,324 16 0.06 1,692 -22.40 0.0008
2022-11-15 2022-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 25,308 -99 -0.39 2,179 -3.88 0.0011
2022-08-15 2022-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 25,407 44 0.17 2,267 -20.54 0.0010
2022-05-13 2022-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 25,363 124 0.49 2,853 -26.81 0.0011
2022-02-14 2021-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 25,239 -2,295 -8.34 3,898 1.62 0.0014
2021-11-10 2021-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 27,534 -14,368 -34.29 3,836 -30.22 0.0015
2021-07-30 2021-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 41,902 -2,960 -6.60 5,497 -19.62 0.0022
2021-05-06 2021-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 44,862 817 1.85 6,839 56.14 0.0030
2021-02-08 2020-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 44,045 -16,563 -27.33 4,380 -24.18 0.0021
2020-11-12 2020-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 60,608 -6,623 -9.85 5,777 -23.18 0.0031
2020-08-13 2020-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 67,231 -910 -1.34 7,520 51.77 0.0044
2020-05-14 2020-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 68,141 280 0.41 4,955 -29.98 0.0036
2020-02-18 2019-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 67,861 -1,730 -2.49 7,077 2.17 0.0040
2019-11-14 2019-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 69,591 -1,200 -1.70 6,927 -14.28 0.0043
2019-08-14 2019-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 70,791 -3,050 -4.13 8,081 -12.95 0.0050
2019-05-14 2019-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 73,841 2,830 3.99 9,283 -3.66 0.0060
2019-02-13 2018-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 71,011 24,602 53.01 9,636 -24.36 0.0072
2018-11-08 2018-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 46,409 -300 -0.64 12,739 31.64 0.0083
2018-08-13 2018-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 46,709 970 2.12 9,677 28.10 0.0067
2018-05-14 2018-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 45,739 -320 -0.69 7,554 19.77 0.0055
2018-02-13 2017-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 46,059 0 0.00 6,307 0.57 0.0045
2017-11-13 2017-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 46,059 0 0.00 6,271 12.14 0.0047
2017-08-10 2017-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 46,059 7,660 19.95 5,592 37.60 0.0043
2017-05-11 2017-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 38,399 5,990 18.48 4,064 23.41 0.0032
2017-02-13 2016-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 32,409 0 0.00 3,293 -0.45 0.0027
2016-11-10 2016-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 32,409 0 0.00 3,308 -14.41 0.0028
2016-08-11 2016-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 32,409 4,600 16.54 3,865 29.79 0.0033
2016-05-13 2016-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 27,809 -3,200 -10.32 2,978 -11.42 0.0025
2016-02-16 2015-12-31 13F/A-1 LIGAND PHARMACEUTICALS COM NEW 53220K504 31,009 -3,750 -10.79 3,362 12.93 0.0029
2016-02-12 2015-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 31,009 2,656
2015-11-13 2015-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 34,759 -4,030 -10.39 2,977 -23.94 0.0026
2015-08-14 2015-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 38,789 -1,000 -2.51 3,914 27.57 0.0032
2015-05-13 2015-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 39,789 0 0.00 3,068 44.92 0.0025
2015-02-13 2014-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 39,789 0 0.00 2,117 13.21 0.0018
2014-11-13 2014-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 39,789 0 0.00 1,870 -24.54 0.0016
2014-08-13 2014-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 39,789 -105 -0.26 2,478 -7.64 0.0021
2014-05-13 2014-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 39,894 5,993 17.68 2,683 50.48 0.0023
2014-02-13 2013-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 33,901 -1,894 -5.29 1,783 15.11 0.0016
2013-11-14 2013-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 35,795 -2,320 -6.09 1,549 8.63 0.0015
2013-08-13 2013-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 38,115 38,115 1,426 0.0015
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.